Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 480 word(s) 480 2020-12-15 07:34:21

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Xu, R. PPM-X Syndrome. Encyclopedia. Available online: (accessed on 20 April 2024).
Xu R. PPM-X Syndrome. Encyclopedia. Available at: Accessed April 20, 2024.
Xu, Rita. "PPM-X Syndrome" Encyclopedia, (accessed April 20, 2024).
Xu, R. (2020, December 24). PPM-X Syndrome. In Encyclopedia.
Xu, Rita. "PPM-X Syndrome." Encyclopedia. Web. 24 December, 2020.
PPM-X Syndrome

PPM-X syndrome is a condition characterized by psychotic disorders (most commonly bipolar disorder), a pattern of movement abnormalities known as parkinsonism, and mild to severe intellectual disability with impaired language development.

genetic conditions

1. Introduction

Other symptoms may include muscle stiffness (spasticity), exaggerated reflexes, and an abnormally small head (microcephaly). Affected males may have enlarged testes (macro-orchidism). Not all affected individuals have all these symptoms, but most have intellectual disability. Males with this condition are typically more severely affected than females, who usually have only mild intellectual disability or learning disabilities.

2. Frequency

PPM-X syndrome is thought to be a very rare condition, although its prevalence is unknown.

3. Causes

Mutations in the MECP2 gene cause PPM-X syndrome. The MECP2 gene provides instructions for making a protein called MeCP2 that is critical for normal brain function. Researchers believe that this protein has several functions, including regulating other genes in the brain by switching them off when they are not needed. The MeCP2 protein likely plays a role in maintaining connections (synapses) between nerve cells. The MeCP2 protein may also control the production of different versions of certain proteins in nerve cells. Although mutations in the MECP2 gene disrupt the normal function of nerve cells, it is unclear how these mutations lead to the signs and symptoms of PPM-X syndrome.

Some MECP2 gene mutations that cause PPM-X syndrome disrupt attachment (binding) of the MeCP2 protein to DNA, and other mutations alter the 3-dimensional shape of the protein. These mutations lead to the production of an MeCP2 protein that cannot properly interact with DNA or other proteins and so cannot control the expression of genes. It is unclear how MECP2 gene mutations lead to the signs and symptoms of PPM-X syndrome, but misregulation of genes in the brain likely plays a role.

4. Inheritance

More than 99 percent of PPM-X syndrome cases occur in people with no history of the disorder in their family. Many of these cases result from new mutations in the MECP2 gene.

A few families with more than one affected family member have been described. These cases helped researchers determine that PPM-X syndrome has an X-linked pattern of inheritance. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes in each cell. In males, who have only one X chromosome, a mutation in the only copy of the gene in each cell is sufficient to cause the condition. In females, who have two copies of the X chromosome, one altered copy of the gene in each cell can lead to less severe features of the condition or may cause no signs or symptoms at all. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

5. Other Names for This Condition

  • MRXS13
  • PPMX
  • X-linked mental retardation, syndromic 13


  1. Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol. 2006 Apr;2(4):212-21. Review.
  2. Gonzales ML, LaSalle JM. The role of MeCP2 in brain development andneurodevelopmental disorders. Curr Psychiatry Rep. 2010 Apr;12(2):127-34. doi:10.1007/s11920-010-0097-7. Review.
  3. Lambert S, Maystadt I, Boulanger S, Vrielynck P, Destrée A, Lederer D,Moortgat S. Expanding phenotype of p.Ala140Val mutation in MECP2 in a 4generation family with X-linked intellectual disability and spasticity. Eur J MedGenet. 2016 Oct;59(10):522-5. doi: 10.1016/j.ejmg.2016.07.003.
  4. Psoni S, Sofocleous C, Traeger-Synodinos J, Kitsiou-Tzeli S, Kanavakis E,Fryssira-Kanioura H. Phenotypic and genotypic variability in four males withMECP2 gene sequence aberrations including a novel deletion. Pediatr Res. 2010May;67(5):551-6. doi: 10.1203/PDR.0b013e3181d4ecf7.
  5. Villard L. MECP2 mutations in males. J Med Genet. 2007 Jul;44(7):417-23.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 615
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020